Our laboratory provides state-of-the-art services in the detection of acquired chromosomal abnormalities associated with hematological malignancies and solid tumors. We offer all available cytogenetic techniques to identify the type and nature of complex structural abnormalities present in malignant (cancerous) cells. We also offer fluorescence in situ hybridization testing using disease-specific panels (more than 100 FISH probes) and a high resolution comparative genomic hybridization + single nucleotide polymorphisms (aCGH+SNP) array for detection of loss, gain, or copy number loss of heterozygosity in cancer related genes.
We offer a full range of services for clinicians and researchers from Mount Sinai and beyond, including the following assays:
- Cell culture
- Routine G-banded chromosome analysis
- Interphase, metaphase and multicolor FISH studies (using more than 100 FISH probes)
- Array CGH (comparative genomic hybridization)+ single nucleotide polymorphisms (SNPs), Agilent Cancer Platform